Biolase, inc (BIOL)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Products and services revenue

37,787

46,143

46,798

51,661

48,269

47,511

56,186

57,191

48,419

24,580

42,137

License fees and royalty revenue

12

12

128

149

206

145

244

165

439

1,645

1,210

Net revenue

37,799

46,155

46,926

51,810

-

-

-

-

-

-

-

Net revenue

-

-

-

-

48,475

47,656

56,430

57,356

48,858

26,225

43,347

Cost of revenue

-

-

-

-

-

-

-

-

-

17,400

-

Cost of revenue

23,511

29,260

31,800

31,502

32,525

29,484

34,900

30,878

-

17,400

23,285

Cost of revenue

-

-

-

-

-

-

-

-

27,540

-

-

Gross profit

14,288

16,895

15,126

20,308

15,950

18,172

21,530

26,478

21,318

8,825

20,062

Operating expenses:
Sales and marketing

14,396

18,121

16,718

17,018

18,696

16,375

18,682

16,250

13,075

9,938

11,041

General and administrative

10,748

11,771

9,712

10,453

10,256

14,854

9,377

8,075

7,936

6,557

7,835

Engineering and development

4,765

5,203

6,229

7,799

7,283

4,577

4,029

4,684

4,311

3,790

4,146

Disposal of internally developed software

-

-1,185

-505

-

-

-

-

-

-

-

-

Change in fair value of patent litigation settlement liability

-

-1,500

-

-

-

-

-

-

-

-

-

Excise tax

-

-

-

-

361

307

438

-

0

-

-

Legal settlement

-

-

-

-

731

-

-

-

-

-

-

Impairment of property, plant and equipment

-

-

-

-

-

-

-

-

-

35

-

Total operating expenses

29,909

37,780

33,164

35,270

35,865

36,113

32,526

29,009

25,322

20,320

23,022

Loss from operations

-15,621

-20,885

-18,038

-14,962

-19,915

-17,941

-10,996

-2,531

-4,004

-11,495

-2,960

Loss on foreign currency transactions

-121

-58

563

-332

-259

-415

-50

-175

-88

-110

176

Interest expense

-2,157

-510

42

74

74

-458

-600

-

-305

-

-

Interest expense, net

-

-

-

-

-

-

-

239

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

3

5

Interest expense

-

-

-

-

-

-

-

-

-

361

58

Non-operating loss (income), net

-2,278

-568

605

-258

-185

-873

-650

-414

-393

-468

123

Loss before income tax provision

-17,899

-21,453

-17,433

-15,220

-20,100

-18,814

-11,646

-

-

-

-

Loss before income tax provision

-

-

-

-

-

-

-

-2,945

-4,397

-11,963

-2,837

Income tax provision

-44

63

-582

151

178

112

-164

111

89

58

119

Net loss

-17,855

-21,516

-16,851

-15,371

-20,278

-18,926

-11,482

-3,056

-4,486

-12,021

-2,956

Other comprehensive income item:
Foreign currency translation adjustment

-31

-94

300

-75

-244

-283

46

40

-36

-102

-

Comprehensive loss

-17,886

-21,610

-16,551

-15,446

-20,522

-19,209

-11,436

-3,016

-4,522

-12,123

-

Net loss

-17,855

-21,516

-16,851

-15,371

-20,278

-18,926

-11,482

-3,056

-4,486

-12,021

-2,956

Deemed dividend on convertible preferred stock

-

-

3,978

2,184

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-17,855

-21,516

-20,829

-17,555

-20,278

-18,926

-

-

-

-

-

Net loss per share:
Basic

-0.77

-1.05

-1.41

-1.45

-0.35

-0.45

-0.35

-0.10

-0.15

-0.46

-0.12

Diluted

-0.77

-1.05

-1.41

-1.45

-0.35

-0.45

-0.35

-0.10

-0.15

-0.46

-0.12

Shares used in the calculation of net loss per share:
Basic

23,201

20,588

14,752

12,133

58,189

42,232

32,768

32,162

30,575

26,250

25,448

Diluted

23,201

20,588

14,752

12,133

58,189

42,232

32,768

32,162

30,575

26,250

25,448